Uso do propofol (2,6 diisopropilfenol) como inibidor da lesão tecidual na isquemia e reperfusão mesentérica: estudo experimental em ratos

PURPOSE: Evaluate the effects of propofol as inhibitor of tissue lesion in mesenteric ischemia and reperfusion in rats. METHODS: Forty rats Wistar were submitted to anesthesia and middle laparotomy. Intestinal ischemia was obtained by false ligature of cranial mesenteric artery by thirty minutes. Then, the tissue was reperfused for sixty minutes. The half of the animals received physiologic solution 0,9% 10 ml/kg/h (control group) by intravenous infusion; the other half received propofol 20 mg/kg/h by same way (propofol group). At the end, a segment of intestine was taken for histologycal analysis. The results were analyzed in agreement with CHIU et al 80 classification and the statistical analysis was done. RESULTS: In the control group was founded 5 rats with classification grade 2; 8 with classification grade 3; 3 with classification grade 4 and 4 rats with grade. In the propofol group was found 6 rats with classification grade 1; 11 with classification grade 2 and 3 with classification grade 3. The classification media was 3,3 for control group and 1,85 for the propofol group. The variation in the two groups was considered statistically significant (P < 0,05). CONCLUSION: The propofol minimize the tissue lesion in mesenteric ischemia and reperfusion in rats.

[1]  H. Scheld,et al.  Diagnosis and treatment of nonocclusive mesenteric ischemia after open heart surgery. , 2001, The Annals of thoracic surgery.

[2]  W. B. Yoshida,et al.  Estudo da ação do extrato de Ginkgo biloba e amido hidroxietílico hipertônico na atenuação de alterações decorrentes de isquemia e reperfusão de órgãos esplâncnicos em ratos , 2001 .

[3]  M. Brito,et al.  Lesão intestinal após isquemia-reperfusão: estudo comparativo usando sal tetrazólico (MTT) e histologia , 2001 .

[4]  S. Imaoka,et al.  Involvement of human liver cytochrome P4502B6 in the metabolism of propofol. , 2001, British journal of clinical pharmacology.

[5]  S. Kong,et al.  Pretreatment With Glycine Reduces the Severity of Warm Intestinal Ischemic-Reperfusion Injury in the Rat , 2001, Annals of plastic surgery.

[6]  Janet Stone,et al.  Impaired fatty acid oxidation in propofol infusion syndrome , 2001, The Lancet.

[7]  Y. Dun,et al.  Role of endogenous opioid peptides in protection of ischemic preconditioning in rat small intestine. , 2001, Life sciences.

[8]  Y. Oh,et al.  Effectiveness of propofol pretreatment on the extent of deranged cerebral mitochondrial oxidative enzyme system after incomplete forebrain ischemia/reperfusion in rats. , 2000, Journal of Korean medical science.

[9]  K. Ushijima,et al.  Intracerebroventricular propofol is neuroprotective against transient global ischemia in rats: extracellular glutamate level is not a major determinant , 2000, Brain Research.

[10]  S. Yamaguchi,et al.  Propofol prevents lipid peroxidation following transient forebrain ischemia in gerbils , 2000, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[11]  P. Tam,et al.  Nitric oxide protects segmental intestinal grafts from ischemia and reperfusion injury. , 2000, Transplantation proceedings.

[12]  M. Caty,et al.  Attenuated nitric oxide synthase activity and protein expression accompany intestinal ischemia/reperfusion injury in rats. , 2000, Biochemical and biophysical research communications.

[13]  T. Shea-Donohue,et al.  Sustained nitric oxide production via l-arginine administration ameliorates effects of intestinal ischemia-reperfusion. , 2000, The Journal of surgical research.

[14]  Fernando Hintz Greca,et al.  Influência do antibiótico nas lesões de isquemia e reperfusão intestinal: estudo experimental em ratos , 2000 .

[15]  H. M. Chen,et al.  Aminoguanidine attenuates hemodynamic and microcirculatory derangement in rat intestinal ischemia and reperfusion. , 1999, The Journal of trauma.

[16]  İ. Durak,et al.  Enzymatic antioxidant defence mechanism in rat intestinal tissue is changed after ischemia-reperfusion. Effects of an allopurinol plus antioxidant combination. , 1999, Canadian journal of surgery. Journal canadien de chirurgie.

[17]  E. Deveci,et al.  Histopathological assessment of the prophylactic effect of gingko-biloba extract on intestinal ischemia-reperfusion injury. , 1999, Acta gastro-enterologica Belgica.

[18]  A. Eidelman,et al.  Amelioration of ischemia-reperfusion injury in rat intestine by pentoxifylline-mediated inhibition of xanthine oxidase. , 1999, Journal of pediatric gastroenterology and nutrition.

[19]  Ç. Durakbaşa,et al.  Nitric oxide and endothelin relationship in intestinal ischemia/reperfusion injury , 1998 .

[20]  F. S. de la Cuesta,et al.  The In Vitro Effects of Propofol on Tissular Oxidative Stress in the Rat , 1998, Anesthesia and analgesia.

[21]  D. Menon,et al.  Antioxidant effects of propofol in human hepatic microsomes: concentration effects and clinical relevance. , 1998, British journal of anaesthesia.

[22]  Y. Yao,et al.  The role of gut as a cytokine-generating organ in remote organ dysfunction after intestinal ischemia and reperfusion. , 1998, Chinese medical journal.

[23]  D. Godin,et al.  Propofol enhances red cell antioxidant capacity in swine and humans , 1998, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[24]  M. Lamy,et al.  Increase in antioxidant capacity of plasma during propofol anesthesia. , 1997, Journal of neurosurgical anesthesiology.

[25]  M. Caty,et al.  Mucosa cell regeneration following intestinal ischemia/reperfusion injury in rats. , 1997, Chinese medical journal.

[26]  M. Boros,et al.  Ischemia time dependency of reperfusion injury following complete arterial occlusion of the rat small intestine. , 1995, Transplantation proceedings.

[27]  D. Granger,et al.  Contributions of ischemia and reperfusion to mucosal lesion formation. , 1986, The American journal of physiology.

[28]  H. Scott,et al.  Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. , 1970, Archives of surgery.